T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis)

European Cytokine Network

Volumn 14, Issue 1, 2003, Pages 34-39

  Attarbaschi, Trawat ^a   Willheim, Martin ^a   Ramharter, Michael ^a   Hofmann, Andrea ^a   Wahl, Katharina ^a   Winkler, Heidi ^a   Graninger, Wolfgang ^a   Winkler, Stefan ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokines; EBV; Flow cytometry; Infectious mononucleosis; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; REFERENCE VALUES; T-LYMPHOCYTES;

ALPHAVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0038519272     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Henle G, Henle W, Diehl V. 1968. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 59: 94.
2. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. 1970. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056.
3. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, Stein H. 1991. Epstein-Barr latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 88: 4766.
4. Rickinson AB, Kieff E. 1996. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott-Raven: 2397.
5. Andersson J. 1996. Clinical and immunological considerations of Epstein-Barr virus-associated diseases. (Review). Scand. J. Infect. Dis. suppl. 100: 72.
6. +-activated T-cells in primary EBV infection. J. Immunol. 163: 5735.
7. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187: 1395.
8. Foss HD, Herbst H, Hummel M, Araujo I, Latza U, Rancso C, Dallenbach F, Stein H. 1994. Patterns of cytokine gene expression in infectious mononucleosis. Blood 83: 707.
9. Lotz M, Tsoukas CD, Fong S, Dinarello CA, Corsan DA, Vaughan JH. 1986. Release of lymphokines after Epstein-Barr virus infection of in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. J. Immunol. 136: 3636.
10. Andersson J, Isberg B, Christensson B, Veress B, Linde A, Bratel T. 1999. Interferon gamma (IFN-gamma) deficiency in generalized Epstein-Barr virus infection with interstitial lymphoid and granulomatous pneumonia, focal cerebral lesions, and genital ulcers: remission following IFN-γ substitution therapy. Clin. Infect. Dis. 28: 1036.
11. Silins SL, Sherritt MA, Silleri JM, Cross SM, Elliott SL, Bharawaj M, Le TT, Morrison LE, Khanna R, Moss DJ, Suhrbier A, Misko IS. 2001. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 98: 3739.
12. Helminen M, Lahdenpohja N, Hurme M. 1999. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J. Infect. Dis. 180: 496.
13. Penn I. 1998. The role of immunosuppression in lymphoma formation. (Review). Springer Semin. Immunopathol. 20: 343.
14. Savoldo B, Goss J, Liu Z, Huls MH, Doster S, Gee AP, Brenner MK, Heslop HE, Rooney CM. 2001. Generation of autologous Epstein-Barr virus-specific cytotoxic T ceils for adoptive immunotherapy in solid organ transplant recipients. Transplantation 72: 1078.
15. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG. 1998. Reciprocal regulation of Th1-and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect. Immun. 66: 6040.
16. + T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J. Virol. 75: 3740.
17. + T cells as sign of in vivo activation in infectious mononucleosis. Clin. Exp. Immunol. 83: 447.
18. + T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 80: 452.
19. Verbeke CS, Wenthe U, Bergler WF, Zentgraf H. 2000. Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status. Clin. Exp. Immunol. 120: 294.
20. Hurme M, Helminen M. 1998. Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand. J. Immunol. 48: 219.
21. Helminen ME, Kilpinen S, Virta M, Hurme M. 2001. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J. Infect. Dis. 184: 777.
22. Trinchieri G. 2001. Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection. (Review). J. Exp. Med. 194: F53.
23. Bejarano MT, Masucci MG. 1998. Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses. Blood 92: 4256.
24. Garnier JL, Blanc-Brunat N, Vivier G, Rousset F, Touraine JL. 1999. Interleukin-10 in Epstein-Barr virus-associated posttransplant lymphomas. Clin. Transplant. 13: 305.